|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM147985838 |
| 003 |
DE-627 |
| 005 |
20231223044606.0 |
| 007 |
tu |
| 008 |
231223s2004 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0493.xml
|
| 035 |
|
|
|a (DE-627)NLM147985838
|
| 035 |
|
|
|a (NLM)15106557
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 245 |
1 |
0 |
|a What to do about cholesterol now. Here's the take-home message from startling new research findings
|
| 264 |
|
1 |
|c 2004
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 26.04.2004
|
| 500 |
|
|
|a Date Revised 30.11.2018
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Anticholesteremic Agents
|2 NLM
|
| 650 |
|
7 |
|a Cholesterol, HDL
|2 NLM
|
| 650 |
|
7 |
|a Cholesterol, LDL
|2 NLM
|
| 650 |
|
7 |
|a Heptanoic Acids
|2 NLM
|
| 650 |
|
7 |
|a Pyrroles
|2 NLM
|
| 650 |
|
7 |
|a Atorvastatin
|2 NLM
|
| 650 |
|
7 |
|a A0JWA85V8F
|2 NLM
|
| 650 |
|
7 |
|a Pravastatin
|2 NLM
|
| 650 |
|
7 |
|a KXO2KT9N0G
|2 NLM
|
| 773 |
0 |
8 |
|i Enthalten in
|t Heart advisor
|d 1999
|g 7(2004), 1 vom: 03. Jan., Seite 1, 7
|w (DE-627)NLM098274252
|x 1523-9004
|7 nnns
|
| 773 |
1 |
8 |
|g volume:7
|g year:2004
|g number:1
|g day:03
|g month:01
|g pages:1, 7
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 7
|j 2004
|e 1
|b 03
|c 01
|h 1, 7
|